Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
HyperQ
1 other identifier
observational
900
1 country
3
Brief Summary
This will be a registry study that will enroll patients referred for an ECG treadmill test with nuclear myocardial perfusion imaging (MPI). The high frequency QRS (HFQRS) information will be recorded and analyzed automatically and simultaneous with the standard ECG signals by the HyperQ System. Results of subsequent tests performed on each patient will be collected and used to enhance the reliability of designating each patient as a CAD-negative (i.e., no significant coronary artery disease) or a CAD-positive (i.e., significant coronary artery disease).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2011
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 28, 2011
CompletedFirst Posted
Study publicly available on registry
March 29, 2011
CompletedStudy Start
First participant enrolled
May 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2012
CompletedMarch 29, 2012
March 1, 2012
1 year
March 28, 2011
March 28, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
CAD status
The main goal of this registry will be to compare sensitivity, specificity, positive and negative predictive values of the HyperQ HFQRS analysis for detecting the presence of coronary artery disease to that of standard ECG analysis.
one month follow up
Eligibility Criteria
Consecutive patients referred for an exercise ECG treadmill test with nuclear myocardial perfusion imaging (MPI).
You may qualify if:
- years or older
- Referred for exercise MPI due to suspected coronary artery disease
You may not qualify if:
- Acute Coronary Syndrome (Unstable angina/NSTEMI/STEMI)
- Pre-excitation syndrome
- QRS duration \> 120 ms
- Atrial Fibrillation or significant ventricular arrhythmia
- Treatment with Digoxin
- Pacemaker with 100% pacemaker dependence
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota, 55407, United States
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
University of Virginia
Charlottesville, Virginia, 22908, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jamieson M Bourque, MD
University of Virginia Health System
- PRINCIPAL INVESTIGATOR
Robert Schwartz, MD
Minneapolis Heart Institute Foundation
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 28, 2011
First Posted
March 29, 2011
Study Start
May 1, 2011
Primary Completion
May 1, 2012
Study Completion
May 1, 2012
Last Updated
March 29, 2012
Record last verified: 2012-03